14 research outputs found
Chronotropic action of immobilized subtilisins during the perfusion of an isolated rat heart
The pharmacological experiments on isolated organs (ex vivo) are the preferred method for assessing the primary pharmacodynamics of the studied drugs, since this method is completely excluded the systemic influence of neurohumoral regulation. In the last decade, a new group of thrombolytic drugs based on immobilized subtilisins has been formed. At the stage of registrational preclinical and clinical studies, their pleiotropic pharmacological effects have not been studied. Meanwhile, there is a reason to consider that their pharmacological activity in the bloodstream is not limited to thrombolytic action, but may be extended to a systemic effect on the cardiovascular system.Β The aim of the study was to investigate the chronotropic effects of an isolated heart during its perfusion with solutions of immobilized subtilisins at different concentrations.Β Material and methods. The isolated rat heart model according to Langendorff was used in the study. The experiment included 50 Wistar rats, which were divided into 5 groups: isolated hearts perfused only with Krebs β Henseleit solution (control) or with immobilized subtilisins in 4 concentrations (170, 340, 510 ΠΈ 1020 U/l).Β Results and discussion. The immobilized subtilisins have a negative chronotropic effect. The onset of the effect depends on the drug concentration in the solution: the higher concentration, the earlier effect. From 5 to 10 minutes of perfusion, a negative chronotropic effect is observed using of immobilized subtilisins at any dose. The duration of its increase is manifested up to 10β20 minutes, depending on the drug concentration in solution. After 20 minutes of perfusion, the achieved negative chronotropic effect remains at a plateau level up to 40 minutes.Β Conclusion. The immobilized subtilisins have an independent pharmacological effect on heart rate
Studying the pharmacokinetic parameters of new normothymic drug based on the complex of lithium citrate, aluminum oxide and polymethylsiloxane
For the treatment of bipolar affective disorders, lithium preparations are the most famous and effective. But the main problem with the use of lithium preparations is the narrow Β«therapeutic corridorΒ». An urgent task is the creation of dosage forms of lithium with a slow release and a wide therapeutic range. The study object was a new normotymic drug based on lithium, aluminum oxide and polymethylsiloxane. Due to the new carrier matrix lithium is released from its porous structure gradually providing a prolonged effect and maintaining an optimal concentration in the blood which also helps to minimize side effects. The purpose of the study was to explore the pharmacokinetic parameters of a normotymic drug based on a complex lithium citrate, aluminum oxide and polymethylsiloxane (LOAP).Material and methods: for the assessment of pharmacokinetic parameters the method of atomic emission spectrometry with inductively coupled plasma and two-chamber modeling were used.Results and discussion. The pharmacokinetic data showed a linear nature of pharmacokinetics of the drug based on LOAP as the foundation of data of the lithiumβs amount in the blood plasma of rabbits after intragastric administration at doses of 200, 400 and 800 mg/kg. The drug with intragastric administration at a dose of 800 mg/kg is well absorbed from the gastrointestinal tract, with bioavailability (F) 74 %. This dose shows the maximum increase of the area under the pharmacokinetic curve (AUC - 32787.1 (ng x h)/ ml), and indicators of elimination constant (Kel - 0.062 h-1), clearance (Cl - 0.09 l/(kg x h)), elimination half-life (T1/2p - 11.436 h) in comparison with other doses remain unchanged
GENDER DIFFERENCES OF ANTHROPOMETRIC CHARACTERISTICS, APPROPRIATE HEART RATE AND THE STRESS RESISTANCE INDEX OF EARLY ADOLESCENTS LIVING ON THE TERRITORY OF KRASNODAR KRAI AND THE REPUBLIC OF KABARDINO-BALKARI
Aim. To find out gender features of anthropometric characteristics, to define average index value of stress resistance of young teenagers living on the territory of Krasnodar Krai and the Republic of Kabardino-Balkaria.Materials and methods. Data on body height, weight, arterial blood pressure and pulse of 140 children (70 girls and 70 boys) at the age of 13,2Β±1,6 years living in the Republic of Kabardino-Balkaria as well as 137 children (70 boys and 67 girls) at the age of 13,4Β±0,1 year living on the territory of Krasnodar Krai (The Belorechensk and Crimean Districts) are collected and subjected to the statistical analysis. The appropriate number of heartbeat, total body area, the level of endured stress were determined by the formulas developed by Yu.R. Sheykh-Zade. Digital material is processed by the method of variation statistics in the Microsoft Excel program.Results. The carried-out statistical analysis showed that anthropometric parameters are lower in thirteen-year old boys living in the Republic of Kabardino-Balkaria than in inhabitants of various parts of Krasnodar Krai: body weight (47,63Β±1,75 and 52,56Β±1,02 kg respectively), body area (14279,54Β±176,54 and 15109,95Β±181,67 cm2 respectively), index of body weight (19,12Β±0,21 and 20,43Β±0,30 c.u. respectively). Girls at the age of thirteen living in the Republic of KabardinoBalkaria have lower physiological parameters in comparison with inhabitants of Krasnodar Krai: the appropriate number of heartbeat (68,31Β±0,54 and 70,78 Β±0,39 min-1 respectively), stress resistance index (1,14Β±0,23 and 1,28Β±0,05 c.u. respectively).Conclusion. Gender differences of anthropometric and physiological parameters in children of the early teenage period between the stated regions (Krasnodar Krai and the Republic of Kabardino-Balkaria) are determined
ΠΠ½Π°Π»ΠΈΠ· Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·ΠΈ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΎΠ² Π»Π΅Π³ΠΎΡΠ½ΠΎΠΉ Π³Π΅ΠΌΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ Ρ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠΉ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΡΡ Π»Π΅Π³ΠΊΠΈΡ : Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ
Objective: to assess pulmonary hemodynamics and the presence of systolic and/or diastolic dysfunction of the myocardium of the right and left ventricles in patients with COPD, depending on the risk groups (A, B, C, D); to determine the possible directions of pharmacological correction.Methods. Patients (n = 119, including 87 men, mean age - 62.5 Β± 14.8 years) with COPD of risk group A (n = 21) and B (n = 98) (GOLD, 2019). In addition to the routine clinical and instrumental examinations, pulmonary and aortic pulse wave velocity was determined using MRI diagnostics.Results. The right ventricular diastolic dysfunctions (DD) were revealed in all patients with COPD (E/A TV = 0.85 Β± 0,03 vs 0.97 Β± 0,03; groups A and B respectively, p < 0,05). 28.6% of patients of group B had a restrictive type of transtricuspid blood flow (p < 0,05). The pulmonary blood pressure was increased: 24.3 Β± 7.6 mm Hg in patients with COPD group A, 17.2 Β± 6.8 mm Hg - in group B. Patients of group B had a higher pulmonary pulse wave velocity (pPWV) (B: 3.13 [2.93-3.44] ms-1 vs A: 1.97 [1.62-2.68] ms-1, p = 0.005) and stroke volume of RV (B: 33.5 [27.3-37.9] mL vs A: 29.1 [24.0-35.7] mL, p = 0.005). The correlation between pPWV and the degree of bronchial obstruction, ejection fraction and end-diastolic volume of the RV, and mean pulmonary arterial pressure (mPAP) was strong for patients of group B and moderate for patients of group A.Conclusion. Thus, patients with COPD risk group A have the borderline indicators of mPAP with DD of LV and RV. The progression of hemodynamic disorders is associated with the aggravation of of clinical symptoms and respiratory disorders, that were more pronounced in group B. This progression led to mandatory broncholytic drug correction.Π¦Π΅Π»ΡΡ ΡΠ°Π±ΠΎΡΡ ΡΠ²ΠΈΠ»Π°ΡΡ ΠΎΡΠ΅Π½ΠΊΠ° Π»Π΅Π³ΠΎΡΠ½ΠΎΠΉ Π³Π΅ΠΌΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ ΠΈ Π½Π°Π»ΠΈΡΠΈΡ ΡΠΈΡΡΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈ / ΠΈΠ»ΠΈ Π΄ΠΈΠ°ΡΡΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ (ΠΠ) ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π° ΠΏΡΠ°Π²ΠΎΠ³ΠΎ (ΠΠ) ΠΈ Π»Π΅Π²ΠΎΠ³ΠΎ (ΠΠ) ΠΆΠ΅Π»ΡΠ΄ΠΎΡΠΊΠΎΠ² Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΡΡ Π»Π΅Π³ΠΊΠΈΡ
(Π₯ΠΠΠ) Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΠΏΡΠΈΠ½Π°Π΄Π»Π΅ΠΆΠ½ΠΎΡΡΠΈ ΠΊ ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· Π³ΡΡΠΏΠΏ ΡΠΈΡΠΊΠ° (ABCD) ΡΠΎΠ³Π»Π°ΡΠ½ΠΎ ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ ΠΠ»ΠΎΠ±Π°Π»ΡΠ½ΠΎΠΉ ΡΡΡΠ°ΡΠ΅Π³ΠΈΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ, Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ Π₯ΠΠΠ (Global Initiative for Chronic Obstructive Lung Disease β GOLD, 2019) Π° ΡΠ°ΠΊΠΆΠ΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΡ
Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠΉ ΠΌΠ΅Π΄ΠΈΠΊΠ°ΠΌΠ΅Π½ΡΠΎΠ·Π½ΠΎΠΉ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ Π±ΠΎΠ»ΡΠ½ΡΠ΅ Π₯ΠΠΠ (n = 119, 87 ΠΌΡΠΆΡΠΈΠ½; ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ - 62,5 Β± 14,8 Π³ΠΎΠ΄Π°) Π³ΡΡΠΏΠΏ ΡΠΈΡΠΊΠ° Π (n = 21) ΠΈ Π (n = 98) ΠΏΠΎ GOLD (2019). ΠΠΎΠΌΠΈΠΌΠΎ ΠΎΠ±ΡΠ΅ΠΏΡΠΈΠ½ΡΡΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΠΈΠ½ΡΡΡΡΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΡ
ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ, ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΎΡΡ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π°ΠΎΡΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΈ Π»Π΅Π³ΠΎΡΠ½ΠΎΠΉ ΡΠΊΠΎΡΠΎΡΡΠΈ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½ΠΈΡ ΠΏΡΠ»ΡΡΠΎΠ²ΠΎΠΉ Π²ΠΎΠ»Π½Ρ (Π»Π‘Π ΠΠ) Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π£ Π²ΡΠ΅Ρ
Π±ΠΎΠ»ΡΠ½ΡΡ
Π₯ΠΠΠ Π²ΡΡΠ²Π»Π΅Π½Ρ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ Π² Π²ΠΈΠ΄Π΅ ΠΠ ΠΠ (ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΠΊΠΎΡΠΎΡΡΠΈ ΡΠ°Π½Π½Π΅Π³ΠΎ Π΄ΠΈΠ°ΡΡΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π½Π°ΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ ΠΊ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΠΊΠΎΡΠΎΡΡΠΈ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄Π½ΠΎΠ³ΠΎ Π΄ΠΈΠ°ΡΡΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π½Π°ΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ (Π / ΠΠΠ) Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° Π ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΎ 0,85 Β± 0,03 vs 0,97 Β± 0,03 - Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° Π;Ρ < 0,05). Π£ 28,6 % Π±ΠΎΠ»ΡΠ½ΡΡ
Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° Π (Ρ < 0,05) ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΡΡ ΡΠ΅ΡΡΡΠΈΠΊΡΠΈΠ²Π½ΡΠΉ ΡΠΈΠΏ ΡΡΠ°Π½ΡΡΡΠΈΠΊΡΡΠΏΠΈΠ΄Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΊΡΠΎΠ²ΠΎΡΠΎΠΊΠ°. ΠΠ΅Π³ΠΎΡΠ½Π°Ρ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π₯ΠΠΠ Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° Π ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 24,3 Β± 7,6 ΠΌΠΌ ΡΡ. ΡΡ., Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° Π - 17,2 Β± 6,8 ΠΌΠΌ ΡΡ. ΡΡ. Π£ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° Π ΠΎΡΠΌΠ΅ΡΠ΅Π½Ρ Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊΠΈΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΡ Π»Π‘Π ΠΠ (3,13 (2,93-3,44) ΠΌΡ-1 vs 1,97 (1,62-2,68) ΠΌΡ-1 Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° A; Ρ = 0,005) ΠΈ ΡΠ΄Π°ΡΠ½ΠΎΠ³ΠΎ ΠΎΠ±ΡΠ΅ΠΌΠ° ΠΠ (33,5 (27,3-37,9) ΠΌΠ» Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° Π vs 29,1 (24,0-35,7) ΠΌΠ» - Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° Π; Ρ = 0,005). Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π° ΡΠΈΠ»ΡΠ½Π°Ρ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π»Π‘Π ΠΠ ΡΠΎ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ Π±ΡΠΎΠ½Ρ
ΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠΈ, ΡΡΠ°ΠΊΡΠΈΠΈ Π²ΡΠ±ΡΠΎΡΠ° ΠΈ ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΠ³ΠΎ Π΄ΠΈΠ°ΡΡΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΡΠ΅ΠΌΠ° ΠΠ, ΡΡΠ΅Π΄Π½Π΅Π³ΠΎ Π΄Π°Π²Π»Π΅Π½ΠΈΡ Π² Π»Π΅Π³ΠΎΡΠ½ΠΎΠΉ Π°ΡΡΠ΅ΡΠΈΠΈ (ΠΠΠΡΡ.) Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π³ΡΡΠΏΠΏΡ Π ΠΈ ΡΠΌΠ΅ΡΠ΅Π½Π½ΠΎΠΉ ΡΠΈΠ»Ρ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΡ - Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° Π.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π’Π°ΠΊΠΈΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π₯ΠΠΠ Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° Π ΠΏΠΎ GOLD (2019) ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΡΡΡΡ ΠΏΠΎΠ³ΡΠ°Π½ΠΈΡΠ½ΡΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΠΠΠΡΡ. Ρ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌ ΠΠ ΠΠ ΠΈ ΠΠ. ΠΡΠΎΠ³ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π³Π΅ΠΌΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ ΡΠ²ΡΠ·Π°Π½ΠΎ Ρ ΡΡΡΠΆΠ΅Π»Π΅Π½ΠΈΠ΅ΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠΉ ΠΈ Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΡΡ
ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ², Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΡ
Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΡΠΈΡΠΊΠ° Π, ΠΏΡΠΈ ΡΡΠΎΠΌ ΡΡΠ΅Π±ΡΠ΅ΡΡΡ ΠΎΠ±ΡΠ·Π°ΡΠ΅Π»ΡΠ½Π°Ρ Π±ΡΠΎΠ½Ρ
ΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΌΠ΅Π΄ΠΈΠΊΠ°ΠΌΠ΅Π½ΡΠΎΠ·Π½Π°Ρ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΡ